ESR1 and breast cancer: In ER+/PR+ cells, P4 promotes proliferation via a cyclin D1-dependent, cell-intrinsic mechanism and overexpression and amplification of Cyclin D1 correlates with poor prognosis in women diagnosed with ER+/PR+ breast cancers [91,92].